Updated analysis of CALGB (Alliance) 100104 assessing lenalidomide versus placebo maintenance after single autologous stem-cell transplantation for multiple myeloma: a randomised, double-blind, phase 3 trialSarah A. Holstein, Philip L. McCarthy, Sin‐Ho Jung et al.|The Lancet Haematology|2017Cited by 172
Breaking the Age Barrier: Physicians’ Perceptions of Candidacy for Allogeneic Hematopoietic Cell Transplantation in Older AdultsAsmita Mishra, Andrew Artz, Parastoo B. Dahi et al.|Transplantation and Cellular Therapy|2021Cited by 32
Transplant Physicians’ Attitudes on Candidacy for Allogeneic Hematopoietic Cell Transplantation (HCT) in Older Patients: The Need for a Standardized Geriatric Assessment (GA) ToolAsmita Mishra, Andrew Artz, Jaime M. Preussler et al.|Transplantation and Cellular Therapy|2020Cited by 6